Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Dividends Paid - Common (2019 - 2025)

Historic Dividends Paid - Common for Pharma-Bio Serv (PBSV) over the last 8 years, with Q2 2025 value amounting to $1.7 million.

  • Pharma-Bio Serv's Dividends Paid - Common fell 13.46% to $1.7 million in Q2 2025 from the same period last year, while for Oct 2025 it was $1.7 million, marking a year-over-year decrease of 5006.73%. This contributed to the annual value of $1.7 million for FY2025, which is 13.46% down from last year.
  • Latest data reveals that Pharma-Bio Serv reported Dividends Paid - Common of $1.7 million as of Q2 2025, which was down 13.46% from $1.7 million recorded in Q2 2024.
  • In the past 5 years, Pharma-Bio Serv's Dividends Paid - Common ranged from a high of $1.7 million in Q2 2021 and a low of $1.7 million during Q2 2025
  • Its 5-year average for Dividends Paid - Common is $1.7 million, with a median of $1.7 million in 2022.
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first dropped by 18.29% in 2022, then decreased by 2.23% in 2023.
  • Quarter analysis of 5 years shows Pharma-Bio Serv's Dividends Paid - Common stood at $1.7 million in 2021, then decreased by 0.18% to $1.7 million in 2022, then dropped by 0.02% to $1.7 million in 2023, then dropped by 0.09% to $1.7 million in 2024, then decreased by 0.13% to $1.7 million in 2025.
  • Its Dividends Paid - Common was $1.7 million in Q2 2025, compared to $1.7 million in Q2 2024 and $1.7 million in Q1 2024.